Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

Satellos Bioscience Inc (MSCL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.5700 0.0000    0.00%
08/08 - Closed. Currency in CAD
Type:  Equity
Market:  Canada
  • Volume: 205,270
  • Bid/Ask: 0.5700 / 0.5900
  • Day's Range: 0.5700 - 0.6200
Satellos Bioscience 0.5700 0.0000 0.00%

Satellos Bioscience Inc Company Profile

 
Get an in-depth profile of Satellos Bioscience Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

16

Equity Type

ORD

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Contact Information

Address Royal Bank Plaza Suite 2800
South Tower 200 Bay Street Toronto, M5J 2J1
Canada
Phone -
Fax -

Top Executives

Name Age Since Title
John R. Perfect - 2018 Member of Clinical Advisory Board
David W. Denning - 2018 Member of Clinical Advisory Board
Coleman Rotstein - 2010 Member of Scientific Advisory Board
Jack D. Sobel - 2010 Member of Scientific Advisory Board
Philip J. Rosenfeld - 2006 Member of Clinical Advisory Board
Thomas J. Walsh - 2010 Member of Scientific Advisory Board
David S. Boyer - 2006 Member of the Clinical Advisory Board
Andrea Leonardi - - Member of the Clinical Advisory Board
Michael Liggett 61 2016 CFO, Corporate Secretary & Director
Julia G. Levy 86 2005 Member of the Strategic Advisory Board
Richard M. Glickman 63 2005 Member of the Strategic Advisory Board
Alan Bird - 2006 Member of the Clinical Advisory Board
Donald N. Buell - - Chairman of the Scientific Advisory Board
Jason Scott Slakter 63 - Member of Clinical Advisory Board
William Wasyl Jarosz 65 2006 Chairman of the Board & CEO
Peter Hnik 65 2006 Chief Medical Officer & Director
Geoff MacKay 58 2018 Independent Chairman of the Board of Directors
Francis Gleeson 69 2012 Co-Founder, CEO, President & Director
Brian Matthew Bloom 48 2018 Independent Director
Perry Shieh - 2024 Member of Clinical Advisory Board
Francesco Muntoni - 2024 Member of Clinical Advisory Board
Richard Finkel - 2024 Member of Clinical Advisory Board
Ronald D. Cohn - 2024 Member of Clinical Advisory Board
Hanns Lochmuller - 2024 Member of Clinical Advisory Board
Iris Loew Friedrich - 2025 Independent Director
Stephanie Brown 64 2024 Independent Director
Selwyn Ho 54 2025 Independent Director
Nicholas Johnson - 2024 Member of Clinical Advisory Board
Franklin M. Berger 76 2023 Independent Director
Jordan S. Dubow 47 2024 Chair of Clinical Advisory Board
Adam S. Mostafa 45 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MSCL Comments

Write your thoughts about Satellos Bioscience Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email